These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11868825

  • 1. Secretory leukocyte proteinase inhibitor and elafin are resistant to degradation by MMP-8.
    Henry MT, McMahon K, Costello C, Fitzgerald MX, O'Connor CM.
    Exp Lung Res; 2002 Mar; 28(2):85-97. PubMed ID: 11868825
    [Abstract] [Full Text] [Related]

  • 2. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S, van der Linden AC, van Sterkenburg MA, Rabe KF, Schalkwijk J, Hiemstra PS.
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [Abstract] [Full Text] [Related]

  • 3. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
    Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J.
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
    [Abstract] [Full Text] [Related]

  • 4. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils.
    Sallenave JM, Si Tahar M, Cox G, Chignard M, Gauldie J.
    J Leukoc Biol; 1997 Jun; 61(6):695-702. PubMed ID: 9201260
    [Abstract] [Full Text] [Related]

  • 5. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung.
    Tremblay GM, Sallenave JM, Israél-Assayag E, Cormier Y, Gauldie J.
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1092-8. PubMed ID: 8887613
    [Abstract] [Full Text] [Related]

  • 6. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
    Zani ML, Baranger K, Guyot N, Dallet-Choisy S, Moreau T.
    Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
    [Abstract] [Full Text] [Related]

  • 7. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins.
    van Wetering S, van der Linden AC, van Sterkenburg MA, de Boer WI, Kuijpers AL, Schalkwijk J, Hiemstra PS.
    Am J Physiol Lung Cell Mol Physiol; 2000 Jan; 278(1):L51-8. PubMed ID: 10645890
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD, Kennedy JA, Zitnik RJ, Kashem MA.
    Biochem Biophys Res Commun; 1999 Jan 27; 254(3):614-7. PubMed ID: 9920787
    [Abstract] [Full Text] [Related]

  • 9. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
    Moreau T, Baranger K, Dadé S, Dallet-Choisy S, Guyot N, Zani ML.
    Biochimie; 2008 Feb 27; 90(2):284-95. PubMed ID: 17964057
    [Abstract] [Full Text] [Related]

  • 10. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
    Baranger K, Zani ML, Labas V, Dallet-Choisy S, Moreau T.
    PLoS One; 2011 Feb 27; 6(6):e20976. PubMed ID: 21687692
    [Abstract] [Full Text] [Related]

  • 11. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells.
    Higashimoto Y, Yamagata Y, Iwata T, Ishiguchi T, Okada M, Masuda M, Satoh H, Itoh H.
    Respiration; 2005 Feb 27; 72(6):629-35. PubMed ID: 16355004
    [Abstract] [Full Text] [Related]

  • 12. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
    Cox SW, Rodriguez-Gonzalez EM, Booth V, Eley BM.
    J Periodontal Res; 2006 Oct 27; 41(5):477-85. PubMed ID: 16953825
    [Abstract] [Full Text] [Related]

  • 13. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome.
    Sallenave JM, Donnelly SC, Grant IS, Robertson C, Gauldie J, Haslett C.
    Eur Respir J; 1999 May 27; 13(5):1029-36. PubMed ID: 10414400
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva.
    Masuda K, Suga T, Takeuchi A, Kanesaki M, Imaizumi A, Suzuki Y.
    Biochem Pharmacol; 1994 Aug 17; 48(4):651-7. PubMed ID: 8080437
    [Abstract] [Full Text] [Related]

  • 16. Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor.
    Mihaila A, Tremblay GM.
    Z Naturforsch C J Biosci; 2001 Aug 17; 56(3-4):291-7. PubMed ID: 11371023
    [Abstract] [Full Text] [Related]

  • 17. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
    Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J.
    J Leukoc Biol; 2007 Apr 17; 81(4):907-15. PubMed ID: 17200145
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
    Zani ML, Tanga A, Saidi A, Serrano H, Dallet-Choisy S, Baranger K, Moreau T.
    Biochem Soc Trans; 2011 Oct 17; 39(5):1441-6. PubMed ID: 21936830
    [Abstract] [Full Text] [Related]

  • 20. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
    Zhang Y, DeWitt DL, McNeely TB, Wahl SM, Wahl LM.
    J Clin Invest; 1997 Mar 01; 99(5):894-900. PubMed ID: 9062347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.